Aspen Pharmacare Holdings Yönetim
Yönetim kriter kontrolleri 4/4
Aspen Pharmacare Holdings CEO'su Stephen Saad, Jan2000 tarihinde atandı, in görev süresi 24.83 yıldır. in toplam yıllık tazminatı ZAR 27.30M olup, şirket hissesi ve opsiyonları dahil olmak üzere 35.2% maaş ve 64.8% ikramiyelerden oluşmaktadır. şirketin hisselerinin 11.82% ine doğrudan sahiptir ve bu hisseler ZAR 9.28B değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 7.7 yıl ve 5.6 yıldır.
Anahtar bilgiler
Stephen Saad
İcra Kurulu Başkanı
R27.3m
Toplam tazminat
| CEO maaş yüzdesi | 35.2% |
| CEO görev süresi | 24.8yrs |
| CEO sahipliği | 11.8% |
| Yönetim ortalama görev süresi | 7.7yrs |
| Yönetim Kurulu ortalama görev süresi | 5.6yrs |
Son yönetim güncellemeleri
Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment
Dec 01
Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation
Dec 02Recent updates
Aspen Pharmacare Holdings Limited (JSE:APN) Not Lagging Market On Growth Or Pricing
Nov 09Aspen Pharmacare Holdings' (JSE:APN) Conservative Accounting Might Explain Soft Earnings
Oct 10Here's Why Aspen Pharmacare Holdings (JSE:APN) Has A Meaningful Debt Burden
Oct 01Aspen Pharmacare Holdings (JSE:APN) Has Announced That It Will Be Increasing Its Dividend To ZAR3.59
Sep 10We Think Aspen Pharmacare Holdings (JSE:APN) Can Stay On Top Of Its Debt
May 08Aspen Pharmacare Holdings Limited's (JSE:APN) P/E Still Appears To Be Reasonable
Mar 05Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet
Dec 22Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment
Dec 01Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet
Mar 31With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Makes An Interesting Case
Jan 11These 4 Measures Indicate That Aspen Pharmacare Holdings (JSE:APN) Is Using Debt Reasonably Well
Oct 22We Ran A Stock Scan For Earnings Growth And Aspen Pharmacare Holdings (JSE:APN) Passed With Ease
Oct 06Aspen Pharmacare Holdings' (JSE:APN) Upcoming Dividend Will Be Larger Than Last Year's
Sep 21Aspen Pharmacare Holdings Limited (JSE:APN) Analysts Just Cut Their EPS Forecasts Substantially
Sep 08Aspen Pharmacare Holdings (JSE:APN) Is Increasing Its Dividend To ZAR3.26
Sep 07Here's Why We Think Aspen Pharmacare Holdings (JSE:APN) Might Deserve Your Attention Today
Jun 15Aspen Pharmacare Holdings (JSE:APN) Seems To Use Debt Quite Sensibly
Apr 02With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Is Interesting
Mar 16An Intrinsic Calculation For Aspen Pharmacare Holdings Limited (JSE:APN) Suggests It's 33% Undervalued
Mar 02Is Aspen Pharmacare Holdings (JSE:APN) A Risky Investment?
Dec 23Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation
Dec 02We Think Aspen Pharmacare Holdings' (JSE:APN) Robust Earnings Are Conservative
Oct 11After Leaping 42% Aspen Pharmacare Holdings Limited (JSE:APN) Shares Are Not Flying Under The Radar
Sep 30Aspen Pharmacare Holdings Limited (JSE:APN) Looks Just Right With A 42% Price Jump
Sep 30CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jun 30 2024 | R27m | R10m | R4b |
| Mar 31 2024 | n/a | n/a | R5b |
| Dec 31 2023 | n/a | n/a | R5b |
| Sep 30 2023 | n/a | n/a | R5b |
| Jun 30 2023 | R24m | R9m | R5b |
| Mar 31 2023 | n/a | n/a | R6b |
| Dec 31 2022 | n/a | n/a | R6b |
| Sep 30 2022 | n/a | n/a | R6b |
| Jun 30 2022 | R23m | R9m | R6b |
| Mar 31 2022 | n/a | n/a | R6b |
| Dec 31 2021 | n/a | n/a | R6b |
| Sep 30 2021 | n/a | n/a | R5b |
| Jun 30 2021 | R24m | R8m | R5b |
| Mar 31 2021 | n/a | n/a | R4b |
| Dec 31 2020 | n/a | n/a | R4b |
| Sep 30 2020 | n/a | n/a | R4b |
| Jun 30 2020 | R23m | R8m | R3b |
| Mar 31 2020 | n/a | n/a | R3b |
| Dec 31 2019 | n/a | n/a | R870m |
| Sep 30 2019 | n/a | n/a | R1b |
| Jun 30 2019 | R14m | R8m | R2b |
| Mar 31 2019 | n/a | n/a | R3b |
| Dec 31 2018 | n/a | n/a | R5b |
| Sep 30 2018 | n/a | n/a | R5b |
| Jun 30 2018 | R17m | R7m | R6b |
Tazminat ve Piyasa: Stephen 'ın toplam tazminatı ($USD 1.55M ) ZA pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 1.55M ).
Tazminat ve Kazançlar: Stephen 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
Stephen Saad (60 yo)
24.8yrs
Görev süresi
R27,303,000
Tazminat
Mr. Stephen Bradley Saad, BCom, CA(SA), serves as the Group Chief Executive Officer of Aspen Pharmacare Canada Inc. Mr. Stephen has been the Group Chief Executive Officer of Aspen Pharmacare Holdings Limit...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Group CEO & Executive Director | 24.8yrs | R27.30m | 11.82% ZAR 9.3b | |
| Group CFO & Executive Director | 25.8yrs | R16.66m | Veri yok | |
| Group Chief Operations Officer & Responsible Pharmacist | 11yrs | R17.18m | Veri yok | |
| Group Chief Advisor | 2.8yrs | R11.14m | 4.32% ZAR 3.4b | |
| Group Chief Corporate Services Officer & Executive Director | less than a year | R13.79m | Veri yok | |
| Group Chief Strategic Development Officer | 4.5yrs | R12.81m | Veri yok | |
| Investor Relations Manager | no data | Veri yok | Veri yok | |
| Group Company Secretary & Chief of Staff | less than a year | Veri yok | Veri yok | |
| Regional Chief Executive Officer of Asia Pacific | 10.8yrs | Veri yok | Veri yok | |
| Chief Executive Officer of Aspen Global Incorporated | 7.7yrs | Veri yok | Veri yok | |
| Corporate Affairs & Investor Relations Executive | no data | Veri yok | Veri yok |
7.7yrs
Ortalama Görev Süresi
54.5yo
Ortalama Yaş
Deneyimli Yönetim: APN 'un yönetim ekibi deneyimli ve deneyimlidir ( 7.7 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Group CEO & Executive Director | 25.8yrs | R27.30m | 11.82% ZAR 9.3b | |
| Group CFO & Executive Director | 2.8yrs | R16.66m | Veri yok | |
| Group Chief Corporate Services Officer & Executive Director | less than a year | R13.79m | Veri yok | |
| Lead Independent Non-Executive Director | 5.6yrs | R1.27m | Veri yok | |
| Non-Executive Director | 25.8yrs | R551.00k | Veri yok | |
| Independent Non-Executive Chairman | 12.6yrs | R1.49m | Veri yok | |
| Independent Non-Executive Director | 2.9yrs | R1.08m | Veri yok | |
| Non-Executive Director | 9.8yrs | R427.00k | Veri yok | |
| Independent Non-Executive Director | 6.3yrs | R1.14m | Veri yok | |
| Independent Non-Executive Director | less than a year | R183.00k | Veri yok | |
| Independent Non-Executive Director | 5.6yrs | R432.00k | Veri yok |
5.6yrs
Ortalama Görev Süresi
57yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: APN 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.6 yıldır).